The clinical parameters of the tumors used in the 2D-DIGE analysis are given in this table: Sex, tumor type, BRCA type, age at diagnosis, ER status, PgR status, RNA subtype classification according to Hu, SĂśrlie, and PAM50 and the associated gel number. (PDF 115 kb
Figure S2. Gene Set Enrichment Analysis (GSEA) analysis between subtypes in breast cancer. (A-F) GSE...
Table S2. Samples sequenced. Sample type, processing and sequencing. (XLSX 51Â kb
90 alternative splicing isoforms with statistically significant (qâ<â0.05) differences between n...
Figure S1. Processing of proteome data. Figure S2. Overlap in identified proteins between our study ...
Table S1. Histological and molecular characteristics of breast tumor tissue samples. Description tab...
Table S1. SVM BRCA1-like status and BRCA1ness-MLPA profiles in 10 breast cancer cell lines. Table S2...
Tables S7. Proteins (nâ=â285) whose abundance in breast tumors correlated with tumor grade. (XLS...
Table S1. Clinical data of TCGA patients. The data was updated with the available follow up informat...
Tables S5. Significantly differentially expressed proteins between breast tumors and adjacent non-ca...
Tables S4. Most differentially expressed proteins between LumA, HER2-positive, and TN/basal-like bre...
Background: Breast cancer is a complex and heterogeneous disease that is usually characterized by hi...
Tables S10. Concordance values (rho) for 5677 protein-mRNA pairs in breast tumors (nâ=â59). (XLS...
Background: Breast cancer is a complex and heterogeneous disease that is usually characterized by hi...
Tables S1. Peptide spectral counts by best ranked UniProt ID for 118 human breast tissues. (XLSX 768...
Tables S6. Concordance between protein-mRNA pairs in breast tumors and adjacent non-cancerous tissue...
Figure S2. Gene Set Enrichment Analysis (GSEA) analysis between subtypes in breast cancer. (A-F) GSE...
Table S2. Samples sequenced. Sample type, processing and sequencing. (XLSX 51Â kb
90 alternative splicing isoforms with statistically significant (qâ<â0.05) differences between n...
Figure S1. Processing of proteome data. Figure S2. Overlap in identified proteins between our study ...
Table S1. Histological and molecular characteristics of breast tumor tissue samples. Description tab...
Table S1. SVM BRCA1-like status and BRCA1ness-MLPA profiles in 10 breast cancer cell lines. Table S2...
Tables S7. Proteins (nâ=â285) whose abundance in breast tumors correlated with tumor grade. (XLS...
Table S1. Clinical data of TCGA patients. The data was updated with the available follow up informat...
Tables S5. Significantly differentially expressed proteins between breast tumors and adjacent non-ca...
Tables S4. Most differentially expressed proteins between LumA, HER2-positive, and TN/basal-like bre...
Background: Breast cancer is a complex and heterogeneous disease that is usually characterized by hi...
Tables S10. Concordance values (rho) for 5677 protein-mRNA pairs in breast tumors (nâ=â59). (XLS...
Background: Breast cancer is a complex and heterogeneous disease that is usually characterized by hi...
Tables S1. Peptide spectral counts by best ranked UniProt ID for 118 human breast tissues. (XLSX 768...
Tables S6. Concordance between protein-mRNA pairs in breast tumors and adjacent non-cancerous tissue...
Figure S2. Gene Set Enrichment Analysis (GSEA) analysis between subtypes in breast cancer. (A-F) GSE...
Table S2. Samples sequenced. Sample type, processing and sequencing. (XLSX 51Â kb
90 alternative splicing isoforms with statistically significant (qâ<â0.05) differences between n...